• Positive completion of pre-development phase of generic version of Skinoren® gel/crème
  • Confirmation of our (degode’s) “generic” Skinoren®- formulation from 5 different regulatory authorities in the EU – thus no bio equivalence studies necessary
  • Closing of an exclusive licensing contract about the generic version of Skinoren® = Beloren® with Aristo Pharma in Berlin for 11 EU countries